FindTrial
Sign In

Role of special protein supplements in muscle mass and strength in cirrhotics

Effect of supplementation of branched chain amino acids on parameters of sarcopenia in patients with liver cirrhosis: A double blind randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019269
Enrollment
60
Registered
2019-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K74- Fibrosis and cirrhosis of liver

Interventions

Intervention1: Branched chain amino acid: Satchet(containing powder) of weight 10g containing about 6g of branched chain amino acid will be the intervention agent. It will be administered twice a day

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of cirrhosis, irrespective of the etiology 2.Age group : 18â??60 years 3.Having sarcopenia 4.Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Patients with overt hepatic encephalopathy, sepsis, active GI bleed or acute kidney injury 2.Known cases of hepatocellular carcinoma 3.Patients having a Child Pugh score of more than 9 4.Any severe chronic illness including congestive heart failure, chronic kidney disease, neuromuscular disorders or HIV 5.History of any chronic drug intake such as corticosteroids 6.Pregnant patients

Design outcomes

Primary

MeasureTime frame
Change in muscle massTimepoint: 6 months—

Secondary

MeasureTime frame
Change in muscle strength, performance and quality of lifeTimepoint: 6 months—

Countries

India

Contacts

Public ContactSrikant Mohta

AIIMS, New Delhi

ansaraya@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026